-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$9.00366.32% Upside
Pyxis Oncology, Inc. Frequently Asked Questions
-
What analysts cover Pyxis Oncology, Inc.?
Pyxis Oncology, Inc. has been rated by research analysts at H.C. Wainwright, Stifel Nicolaus, Jefferies in the past 90 days.